Where is GenScript headquarters in Europe?
GenScript's European Division headquarters is located in Rijswijk, near The Hague in the Netherlands. Established to anchor the company's regional expansion across Western Europe, this administrative and logistical base coordinates continental customer support, commercial distribution networks, and specialized biotechnology facilities, including advanced mRNA production infrastructure located nearby in Delft to service European life science innovators.
Related FAQs
Yes, Genuine Parts Company is the parent company of NAPA Auto Parts. The organization serves as a major distributor of automotive replacement parts, industrial replacement parts, and business products.
GenScript sells an extensive, highly specialized portfolio of biological products, laboratory reagents, custom molecular services, and technical instruments to life science researchers and pharmaceutical developers globally.
GenScript maintains deep structural and operational roots connected to China, alongside a significant international footprint originating from its initial founding origins.
GenScript functions significantly as a specialized Contract Research Organization, providing comprehensive outsourced research support and discovery services to global pharmaceutical companies, academic institutions, and biotechnology firms.
GenScript is fundamentally characterized as a multinational biotechnology corporation with deep operational and executive ties to China, despite its initial establishment in the United States.
GenScript operates as a massive global biotechnology enterprise with its primary corporate headquarters located in Nanjing, China.
Employee feedback regarding GenScript highlights a mixed workplace environment characterized by distinct operational advantages and notable organizational challenges typical of fast-paced multinational biotechnology firms.
GenScript provides a rich spectrum of career opportunities spanning biotechnology research, life science reagents manufacturing, genetic engineering, molecular biology, and commercial operations.
GenScript operates globally under its official corporate legal name, GenScript Biotech Corporation.
GenScript is recognized as a substantial, globally influential player within the biotechnology, life sciences, and contract research sectors, employing thousands of highly skilled personnel and operating extensive facilities across multiple continent...
GenScript Biotech Corporation, a world-leading biotechnology enterprise specializing in life science research services, gene synthesis, and molecular biology tools, has its global headquarters located in Nanjing, Jiangsu Province, China.
GenScript is widely regarded by laboratory professionals and academic researchers as a dependable provider of custom biological reagents and technical services.
Pfizer operates specialized manufacturing facilities and pharmaceutical packaging plants within China to produce various medical products, prescription drugs, and healthcare treatments tailored to supply local clinical markets.
GenScript operates extensively as a Contract Development and Manufacturing Organization through specialized dedicated arms such as GenScript ProBio, which provides comprehensive end-to-end solutions for biological products.
The biotechnology sector features several pioneering enterprises specializing in advanced gene editing and genomic therapeutics, with companies utilizing cutting-edge CRISPR-Cas9 technology standing out as industry leaders.
GenScript is an entirely legitimate, globally recognized biotechnology enterprise that has operated successfully for decades within the international life sciences market.
GenScript Biotech Corporation is a premier global biotechnology and life sciences contract research organization that provides critical research tools, gene synthesis services, and biological reagents to academic institutions, pharmaceutical companie...
George A. Makris Jr., serving in prominent executive leadership as Chairman and Chief Executive Officer of Simmons First National Corporation (Simmons Bank), received a comprehensive executive compensation package valued at approximately 5.
The biotechnology sector features innovative pioneers dedicated to developing transformative genetic medicines, base editing technologies, and rare disease cures.
GenScript is generally considered a reliable and trusted partner within the global scientific community, backed by decades of operational history, strict adherence to international quality standards, and widespread adoption of its products by leading...
GenScript qualifies as a large-scale enterprise when evaluated by its global workforce size, physical infrastructure spread, international market reach, and overall financial capitalization within the biotechnology sector.
United States biotechnology corporations lead the world in scientific innovation, clinical trial execution, and commercial drug delivery. The first major U.S.